Evidence map›Paper›PMID 33050175›Full record

ReviewInternational journal of molecular sciences2020

Periodontal Disease and Senescent Cells: New Players for an Old Oral Health Problem?

Ruben Aquino-Martinez, Sundeep Khosla, Joshua N Farr, David G Monroe

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. The Role of Cellular Senescence in Oral Health and Disease.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Extracellular vimentin amplifies inflammation: Perspectives for immune injury and therapeutics for periodontitis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Pathogens (Basel, Switzerland) · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ruben Aquino-MartinezDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.ORCID 0000-0003-1564-2279
Sundeep KhoslaDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Joshua N FarrDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
David G MonroeDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.ORCID 0000-0002-4818-0114
Mayo Clinic · US

Funding

Targeting Cellular Senescence to Extend HealthspanP01AG062413 · NIA · MAYO CLINIC ROCHESTER · PI Diana Jurk · 2019 to 2026
$28.7M
Targeting Cellular Senescence and RAGE in Type 2 DiabetesR01DK128552 · NIDDK · UNIVERSITY OF ARIZONA · PI FARR, JOSHUA NICHOLAS · 2021 to 2025
$2.0M
The Role of Ror-Beta in the SkeletonR01AR068275 · NIAMS · MAYO CLINIC ROCHESTER · PI MONROE, DAVID G · 2015 to 2019
$1.7M
The Role of miR-219a-5p in Bone MetabolismR01AG063707 · NIA · MAYO CLINIC ROCHESTER · PI MONROE, DAVID G · 2020 to 2024
$1.5M
The Role of Cellular Senescence in Mediating Age-Related Bone LossK01AR070241 · NIAMS · MAYO CLINIC ROCHESTER · PI FARR, JOSHUA NICHOLAS · 2016 to 2020
$640k
Targeting cellular senescence with senolytics to improve skeletal health in older humansR21AG065868 · NIA · MAYO CLINIC ROCHESTER · PI FARR, JOSHUA NICHOLAS, KHOSLA, SUNDEEP · 2020 to 2021
$419k
NIAMS NIH HHS K01 AR070241NIAMS NIH HHS R01 AR068275NIA NIH HHS P01 AG062413NIA NIH HHS R01 AG063707NIA NIH HHS R21 AG065868NIDDK NIH HHS R01 DK128552
6 · The paper itself

Abstract

The recent identification of senescent cells in periodontal tissues has the potential to provide new insights into the underlying mechanisms of periodontal disease etiology. DNA damage-driven senescence is perhaps one of the most underappreciated delayed consequences of persistent Gram-negative bacterial infection and inflammation. Although the host immune response rapidly protects against bacterial invasion, oxidative stress generated during inflammation can indirectly deteriorate periodontal tissues through the damage to vital cell macromolecules, including DNA. What happens to those healthy cells that reside in this harmful environment? Emerging evidence indicates that cells that survive irreparable genomic damage undergo cellular senescence, a crucial intermediate mechanism connecting DNA damage and the immune response. In this review, we hypothesize that sustained Gram-negative bacterial challenge, chronic inflammation itself, and the constant renewal of damaged tissues create a permissive environment for the abnormal accumulation of senescent cells. Based on emerging data we propose a model in which the dysfunctional presence of senescent cells may aggravate the initial immune reaction against pathogens. Further understanding of the role of senescent cells in periodontal disease pathogenesis may have clinical implications by providing more sophisticated therapeutic strategies to combat tissue destruction.

Indexed as

Cellular SenescenceDisease SusceptibilityBacterial InfectionsCellular MicroenvironmentDisease ManagementDNA DamageHost-Pathogen InteractionsHumansInflammationNF-kappa BOral HealthPeriodontal DiseasesPeriodontiumSignal TransductionStress, PhysiologicalNF-kappa Bbacterial infectioncellular senescenceDNA damageimmune responseinflammationmolecular mechanismpathogenesisperiodontal diseaseperiodontitis

Identifiers

PMID33050175
PMCPMC7587987
OpenAlexW3092633709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.